35261-01-9Relevant academic research and scientific papers
Pyrimidine ring-containing substituted five-membered heterocyclic compound as well as preparation method and application thereof
-
Paragraph 0335-0338, (2021/02/06)
The invention discloses a substituted five-membered heterocyclic compound containing pyrimidine rings. The structure is shown in a formula I: (the formula I is shown in the description), and the definition of each substation group is shown in the descript
Pyrimidine-containing fused heterocyclic compounds, and preparation method and application thereof
-
Paragraph 0266-0269, (2020/04/17)
The invention discloses pyrimidine-containing fused heterocyclic compounds, and a preparation method and application thereof. The structures of the pyrimidine-containing fused heterocyclic compounds are as shown in a general formula I which is described in the specification. In the general formula I, each substituent group is as defined in the specification. The compounds provided by the inventionhave broad-spectrum bactericidal activity, and have excellent prevention and treatment effects on cucumber downy mildew, wheat powdery mildew and the like.
Substituted six-membered heterocyclic compound containing pyrimidine rings and preparation method and application thereof
-
Paragraph 0357-0360, (2018/06/04)
The invention discloses a substituted six-membered heterocyclic compound containing pyrimidine rings. The structure is shown in a formula I: (the formula I is shown in the description), and the definition of each substation group is shown in the description. The substituted six-membered heterocyclic compound has the advantages that the broad-spectrum bacteria-killing and insect-killing activity isrealized; the good preventing and controlling effect is realized for cucumber downy mildew, wheat powdery mildew, puccinia polysora, rice blast, cucumber anthracnose and the like; meanwhile, the goodinsect-killing activity is realized.
HCV INHIBITING BI-CYCLIC PYRIMIDINES
-
Page/Page column 29, (2010/10/20)
The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for pre
Bicyclicpyrimidones and their use to treat diseases
-
, (2008/06/13)
The present invention is directed to dihydropyrimidones having formula I or II and methods of using them to induce mitotic arrest, thereby making them useful as anti-cancer agents and other diseases that can be treated by inducing mitotic arrest.
